Mouhieddine, Tarek H. http://orcid.org/0000-0002-1190-5978
Moshier, Erin
Thibaud, Santiago
Puliafito, Benjamin
Rattu, Mohammad
Jakubowski, Rita
Sanchez, Larysa
Rossi, Adriana
Rodriguez, Cesar
Richard, Shambavi
Cho, Hearn Jay http://orcid.org/0000-0003-4481-5757
Parekh, Samir
Chari, Ajai
Steinberg, Amir
Richter, Joshua
Article History
Received: 12 June 2022
Revised: 2 October 2022
Accepted: 6 October 2022
First Online: 19 October 2022
Competing interests
: THM received advisory board fees from Legend Biotech. LS received consulting fees from Takeda. SR received honoraria from Karyopharm and Janssen, and advisory board fees from Karyopharm and Celgene/Bristol Myers Squibb, and research support from Janssen, Celgene/Bristol Myers Squibb, C4 Therapeutics. AR received advisory board fees from Celgene/Bristol Myers Squibb, Janssen, Sanofi, and GlaxoSmithKline. HJC is an employee of the Multiple Myeloma Research Foundation, and received research funding from Celgene/Bristol Myers Squibb, and Takeda. CR received consulting fees from Janssen, Artica, Takeda, Amgen, Karyopham, and Caelum Biosciences. SP received advisory board fees from GRAIL and research support from Celgene/Bristol Myers Squibb, Amgen, and Karyopharm. A.C. received consulting fees from Amgen, Celgene/Bristol Myers Squibb, Janssen, Karyopharm, and Takeda, and advisory board fees from Amgen, Celgene/Bristol Myers Squibb, Janssen, Karyopharm, Takeda, Sanofi, and Seattle Genetics, and research support from Amgen, Array Biopharma, Celgene/Bristol Myers Squibb, GlaxoSmithKline, Janssen, Takeda, Novartis, Oncoceutics, Pharmacyclics and Seattle Genetics. SJ received advisory board fees and consulting fees from Celgene/Bristol Myers Squibb, Janssen, Legend Biotech, Karyopharm, Sanofi and Takeda. J.R. received speaking fees from Celgene/Bristol Myers Squibb, Sanofi, and Janssen, and advisory board fees from Celgene/Bristol Myers Squibb, Janssen, Celgene/Bristol Myers Squibb, Karyopharm, Sanofi, X4 Pharmaceuticals, Oncopeptides, Adaptive Biotechnologies, Secura Bio, Astrazeneca, and Takeda, and consulting fees from Celgene/Bristol Myers Squibb, Secura Bio, and Oncopeptides. EM, ST, BP, MR, RJ, and AS declare no potential conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Informed consent was obtained from all individual participants included in the study.